Wordt geladen...
The Search for New Therapies for Human Cytomegalovirus Infections
Ganciclovir (GCV), the therapy of choice for human cytomegalovirus (CMV) infections and foscarnet, a drug used to treat GCV-resistant CMV infections were approved more than twenty years ago. Although cidofovir and a prodrug of GCV have since been added to the armamentarium, a highly effective drug w...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3068221/ https://ncbi.nlm.nih.gov/pubmed/21095209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virusres.2010.11.004 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|